-transparent.png){kind=logo}
A prospective randomized pilot study of subcutaneous low-dose heparin in the prevention of deep-vein thrombosis and pulmonary embolism was carried out in patients admitted to hospital after intracerebral hemorrhage. A high incidence of deep-vein thrombosis and lung embolism was detected by phleboscintigraphy and lung perfusion scintigraphy, respectively. There was no significant reduction of deep-vein thrombosis and pulmonary embolism in the therapy group. Heparin did not increase the risk of rebleeding.
Related Publications
U Dickmann, and
E Voth, and
H Schicha, and
T Henze, and
H Prange, and
D Emrich
September 1976,
The Western journal of medicine,
U Dickmann, and
E Voth, and
H Schicha, and
T Henze, and
H Prange, and
D Emrich
April 1992,
American heart journal,
U Dickmann, and
E Voth, and
H Schicha, and
T Henze, and
H Prange, and
D Emrich
January 1988,
Cardiovascular and interventional radiology,
U Dickmann, and
E Voth, and
H Schicha, and
T Henze, and
H Prange, and
D Emrich
August 1979,
Fortschritte der Medizin,
U Dickmann, and
E Voth, and
H Schicha, and
T Henze, and
H Prange, and
D Emrich
May 2012,
Lancet (London, England),
U Dickmann, and
E Voth, and
H Schicha, and
T Henze, and
H Prange, and
D Emrich
December 2016,
Lancet (London, England),
U Dickmann, and
E Voth, and
H Schicha, and
T Henze, and
H Prange, and
D Emrich
August 1993,
Lancet (London, England),
U Dickmann, and
E Voth, and
H Schicha, and
T Henze, and
H Prange, and
D Emrich
December 2019,
La Revue du praticien,
U Dickmann, and
E Voth, and
H Schicha, and
T Henze, and
H Prange, and
D Emrich
June 1980,
South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,
U Dickmann, and
E Voth, and
H Schicha, and
T Henze, and
H Prange, and
D Emrich
November 2021,
MMW Fortschritte der Medizin,
